KIF5A and cancer: Specifically, although high expression of KIF5A in LUAD promotes cancer progression, inhibits anoikis, under Ergotamine treatment, the expression of the pro‐cancer gene KIF5A is suppressed, leading to anoikis of the cells, which may play a certain anti‐tumor role.